PAPER Mahapatra A, Newberry RW
SEARCH RESULTS
330913 RESULTS
PAPER Walke G, Kumar R, Wittung-Stafshede P
Copper ion incorporation in α-synuclein amyloids.
Protein Sci. 2024 Apr;33(4):e4956. PubMed: 38511511PAPER Shir D, Corriveau-Lecavalier N, Bermudez Noguera C, Barnard L, Pham NT, Botha H, Duffy JR, Clark HM, Utianski RL, Knopman DS, Petersen RC, Boeve BF, Murray ME, Nguyen AT, Reichard RR, Dickson DW, Day GS, Kremers WK, Graff-Radford NR, Jones DT, Machulda MM, Fields JA, Whitwell JL, Josephs KA, Graff-Radford J
Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
J Neurol Neurosurg Psychiatry. 2024 Mar 21; PubMed: 38514176PAPER Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, Shao L, Yang R, Lin Z, Wu X, Huang TY, Wang Z, Zhang YW, Xu H, Zhao Y
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.
Neuron. 2024 Mar 12; PubMed: 38513667PAPER Mychajliw C, Holz H, Minuth N, Dawidowsky K, Eschweiler GW, Metzger FG, Wortha F
Performance Differences of a Touch-Based Serial Reaction Time Task in Healthy Older Participants and Older Participants With Cognitive Impairment on a Tablet: Experimental Study.
JMIR Aging. 2024 Mar 21;7:e48265. PubMed: 38512340PAPER Wang B, Cui C, Chen Y, Liang Z
The mediating effect of 18F-FDG metabolism in right caudate between depressive symptoms and cognitive function in Alzheimer's disease.
Front Aging Neurosci. 2024;16:1328143. Epub 2024 Mar 6 PubMed: 38511197PAPER Medeiros D, McMurry K, Pfeiffer M, Newsome K, Testerman T, Graf J, Silver AC, Sacchetti P
Slowing Alzheimer's disease progression through probiotic supplementation.
Front Neurosci. 2024;18:1309075. Epub 2024 Mar 6 PubMed: 38510467PAPER Punzi M, Sestieri C, Picerni E, Chiarelli AM, Padulo C, Delli Pizzi A, Tullo MG, Tosoni A, Granzotto A, Della Penna S, Onofrj M, Ferretti A, Delli Pizzi S, Sensi SL, Alzheimer's Disease Neuroimaging Initiative
Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease.
Heliyon. 2024 Mar 30;10(6):e27429. Epub 2024 Mar 8 PubMed: 38509925PAPER Jagust WJ, Mattay VS, Krainak DM, Wang SJ, Weidner LD, Hofling AA, Koo H, Hsieh P, Kuo PH, Farrar G, Marzella L
Quantitative Brain Amyloid PET.
J Nucl Med. 2024 Mar 21; PubMed: 38514082PAPER Gontrum EQ, Paolillo EW, Lee S, Diaz V, Ehrenberg A, Saloner R, Mundada NS, La Joie R, Rabinovici G, Kramer JH, Casaletto K
Neuropsychiatric profiles and cerebral amyloid burden in adults without dementia.
Dement Geriatr Cogn Disord. 2024 Mar 21; PubMed: 38513620PAPER Pak V, Adewale Q, Bzdok D, Dadar M, Zeighami Y, Iturria-Medina Y
Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions.
Elife. 2024 Mar 21;12 PubMed: 38512130PAPER Wang Y, Liu Y, Wang Y, Bai P, Hallisey MR, Varela BL, Siewko A, Wang C, Xu Y
Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds.
Drug Des Devel Ther. 2024;18:819-827. Epub 2024 Mar 15 PubMed: 38511202PAPER Kubota M, Endo H, Takahata K, Tagai K, Suzuki H, Onaya M, Sano Y, Yamamoto Y, Kurose S, Matsuoka K, Seki C, Shinotoh H, Kawamura K, Zhang MR, Takado Y, Shimada H, Higuchi M
In vivo PET classification of tau pathologies in patients with frontotemporal dementia.
Brain Commun. 2024;6(2):fcae075. Epub 2024 Mar 1 PubMed: 38510212PAPER Manera AL, Dadar M, Ducharme S, Collins DL
VentRa: distinguishing frontotemporal dementia from psychiatric disorders.
Brain Commun. 2024;6(2):fcae069. Epub 2024 Feb 27 PubMed: 38510209PAPER Bayram S, Akkaş ÖA
Adaptation of the Australian National University Alzheimer's Disease Risk Index-Short Form (ANU-ADRI-SF) into Turkish.
Int J Older People Nurs. 2024 Mar;19(2):e12608. PubMed: 38509777Current Filters
No filters selected